Kura Oncology
KURA
99 hedge funds and large institutions have $455M invested in Kura Oncology in 2018 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 35 increasing their positions, 35 reducing their positions, and 23 closing their positions.
5.61% more ownership
Funds ownership: 79.61% → 85.21% (+5.6%)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
0% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 35
14% less capital invested
Capital invested by funds: $529M → $455M (-$74.4M)
15% less funds holding
Funds holding: 116 → 99 (-17)
70% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 23
88% less call options, than puts
Call options by funds: $19K | Put options by funds: $154K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
+$18.2M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
+$10.1M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$8.62M |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$7.29M |
| 5 |
FI
Fosun International
Hong Kong,
China
|
+$2.71M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Sio Capital Management
New York
|
-$7.72M |
| 2 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$7.09M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$6.61M |
| 4 |
Millennium Management
New York
|
-$5.53M |
| 5 |
NC
Nexthera Capital
New York
|
-$5.45M |
KURA Hedge Fund Activity: Q4 2018 in Review
99 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in Kura Oncology (KURA) for Q4 2018, worth a combined $455M — down 14% from $529M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of KURA and 7 opened new positions — a net loss of 16 holders — while 35 trimmed existing stakes and 35 added.
The largest buyer was EcoR1 Capital, adding an estimated $18.2M. The largest seller was Sio Capital Management, cutting an estimated $7.72M.
- 99 institutional investors held Kura Oncology (KURA) as of Q4 2018, down from 116 in Q3 2018.
- Funds reported $455M of Kura Oncology stock for Q4 2018, down 14% quarter-over-quarter.
- 7 funds opened new Kura Oncology positions in Q4 2018 and 23 closed out, a net change of -16 holders.
- The largest Kura Oncology buyer in Q4 2018 was EcoR1 Capital, an estimated $18.2M added.
- The largest Kura Oncology seller in Q4 2018 was Sio Capital Management, an estimated $7.72M sold.
Based on aggregated 13F filings for Q4 2018.